Literature DB >> 25221658

Multiple fragment docking and linking in primary and secondary pockets of dopamine receptors.

Márton Vass1, Eva Agai-Csongor1, Ferenc Horti1, György M Keserű2.   

Abstract

A sequential docking methodology was applied to computationally predict starting points for fragment linking using the human dopamine D3 receptor crystal structure and a human dopamine D2 receptor homology model. Two focused fragment libraries were docked in the primary and secondary binding sites, and best fragment combinations were enumerated. Similar top scoring fragments were found for the primary site, while secondary site fragments were predicted to convey selectivity. Three linked compounds were synthesized that had 9-, 39-, and 55-fold selectivity in favor of D3 and the subtype selectivity of the compounds was assessed on a structural basis.

Entities:  

Keywords:  Fragment docking; G protein-coupled receptors; dopamine receptors; fragment linking; selective antagonists

Year:  2014        PMID: 25221658      PMCID: PMC4160746          DOI: 10.1021/ml500201u

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  16 in total

1.  Impact of lipophilic efficiency on compound quality.

Authors:  Akos Tarcsay; Kinga Nyíri; György M Keseru
Journal:  J Med Chem       Date:  2012-01-24       Impact factor: 7.446

2.  Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors.

Authors:  Eva Agai-Csongor; György Domány; Katalin Nógrádi; János Galambos; István Vágó; György Miklós Keserű; István Greiner; István Laszlovszky; Anikó Gere; Eva Schmidt; Béla Kiss; Mónika Vastag; Károly Tihanyi; Katalin Sághy; Judit Laszy; István Gyertyán; Mária Zájer-Balázs; Larisza Gémesi; Margit Kapás; Zsolt Szombathelyi
Journal:  Bioorg Med Chem Lett       Date:  2012-04-04       Impact factor: 2.823

3.  Numerical errors and chaotic behavior in docking simulations.

Authors:  Miklos Feher; Christopher I Williams
Journal:  J Chem Inf Model       Date:  2012-03-13       Impact factor: 4.956

4.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

Authors:  Chris de Graaf; Albert J Kooistra; Henry F Vischer; Vsevolod Katritch; Martien Kuijer; Mitsunori Shiroishi; So Iwata; Tatsuro Shimamura; Raymond C Stevens; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2011-11-07       Impact factor: 7.446

5.  Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.

Authors:  Ellen Y T Chien; Wei Liu; Qiang Zhao; Vsevolod Katritch; Gye Won Han; Michael A Hanson; Lei Shi; Amy Hauck Newman; Jonathan A Javitch; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-11-19       Impact factor: 47.728

6.  Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.

Authors:  Dan Chen; Anirudh Ranganathan; Adriaan P IJzerman; Gregg Siegal; Jens Carlsson
Journal:  J Chem Inf Model       Date:  2013-09-18       Impact factor: 4.956

7.  Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.

Authors:  J Robert Lane; Pavel Chubukov; Wei Liu; Meritxell Canals; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Vsevolod Katritch
Journal:  Mol Pharmacol       Date:  2013-09-10       Impact factor: 4.436

8.  Virtual fragment screening: discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints.

Authors:  Francesco Sirci; Enade P Istyastono; Henry F Vischer; Albert J Kooistra; Saskia Nijmeijer; Martien Kuijer; Maikel Wijtmans; Raimund Mannhold; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  J Chem Inf Model       Date:  2012-12-03       Impact factor: 4.956

9.  Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.

Authors:  Amy Hauck Newman; Thijs Beuming; Ashwini K Banala; Prashant Donthamsetti; Katherine Pongetti; Alex LaBounty; Benjamin Levy; Jianjing Cao; Mayako Michino; Robert R Luedtke; Jonathan A Javitch; Lei Shi
Journal:  J Med Chem       Date:  2012-06-07       Impact factor: 7.446

10.  Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.

Authors:  C Reavill; S G Taylor; M D Wood; T Ashmeade; N E Austin; K Y Avenell; I Boyfield; C L Branch; J Cilia; M C Coldwell; M S Hadley; A J Hunter; P Jeffrey; F Jewitt; C N Johnson; D N Jones; A D Medhurst; D N Middlemiss; D J Nash; G J Riley; C Routledge; G Stemp; K M Thewlis; B Trail; A K Vong; J J Hagan
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

View more
  7 in total

1.  Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.

Authors:  Xiaomeng Xu; Shifan Ma; Zhiwei Feng; Guanxing Hu; Lirong Wang; Xiang-Qun Xie
Journal:  J Mol Graph Model       Date:  2016-08-08       Impact factor: 2.518

Review 2.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

3.  Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?

Authors:  Jon Kapla; Ismael Rodríguez-Espigares; Flavio Ballante; Jana Selent; Jens Carlsson
Journal:  PLoS Comput Biol       Date:  2021-05-13       Impact factor: 4.475

Review 4.  Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design.

Authors:  Shaherin Basith; Minghua Cui; Stephani J Y Macalino; Jongmi Park; Nina A B Clavio; Soosung Kang; Sun Choi
Journal:  Front Pharmacol       Date:  2018-03-09       Impact factor: 5.810

Review 5.  The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.

Authors:  Attila Egyed; Dóra Judit Kiss; György M Keserű
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 6.  A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets.

Authors:  Michael J Wasko; Kendy A Pellegrene; Jeffry D Madura; Christopher K Surratt
Journal:  Front Neurol       Date:  2015-09-11       Impact factor: 4.003

7.  Fingerprint-Based Machine Learning Approach to Identify Potent and Selective 5-HT2BR Ligands.

Authors:  Krzysztof Rataj; Ádám Andor Kelemen; José Brea; María Isabel Loza; Andrzej J Bojarski; György Miklós Keserű
Journal:  Molecules       Date:  2018-05-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.